Back

Anaesthesia strategies for subcutaneous implantable cardioverter-defibrillator implantation: results from the HONEST national registry

12 April 2026 (11:40 - 11:49)
Organised by: Logo
Congress Presentation Part of: Cardiac resynchronisation and implantable cardioverter-defibrillator therapy Implantable Cardioverter-Defibrillator (ICD) EHRA Premium Access EHRA 2026 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Doctor Luca Donisi

Clinic Pasteur, Toulouse (France)

6 More presentations in this session

Presentation thumbnail
The causes of inappropriate shocks differ between the subcutaneous and extravascular implantable cardioverter-defibrillators
Doctor K. Abdelsayed (Minneapolis, US)
Abstract Slides Video
Presentation thumbnail
Sex-specific differences in ventricular dyssynchrony at comparable QRS duration: insights from Ultra-High-Frequency ECG
Doctor F. Klein (Maastricht, NL)
Abstract Slides Video
Presentation thumbnail
Subcutaneous ICD therapy after sternotomy: feasibility and long-term outcomes in a propensity-matched analysis from a national registry
Doctor L. Perrotta (Florence, IT)
Abstract Slides Video
Presentation thumbnail
Ventricular fibrillation during lattice-tip radiofrequency ablation adjacent to ICD coils: a multicenter case series
Doctor B. Kovacs (Bern, CH)
Abstract Slides Video
Presentation thumbnail
The CAVIAR response score accurately predicts long term survival after cardiac resynchronisation therapy.
Ms C. Chiu (Utrecht, NL)
Abstract Slides Video

Access the full session

Session thumbnail
Cardiac resynchronisation and implantable cardioverter-defibrillator therapy
Video

The Event

Event poster

EHRA 2026

12 April 2026 11:40 CET
You may be interested in
thumbnail
Congress Presentation
Subcutaneous implantable cardioverter defibrillator evolved: precise implants, minimal sedation, maximum safety
thumbnail
Congress Presentation
Local anesthesia during S-ICD implantation gives similar post procedural pain perception as sedation
thumbnail
Congress Session
Cardiac resynchronisation and implantable cardioverter-defibrillator therapy

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources